Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3276429

Beta release

Statistics of Long-term efficacy and safety of guselkumab, a monoclonal antibody specific to the p19 subunit of interleukin-23, through two years
Statistics for this year
PeriodVisitsDownloads
20245245
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0933
2024-1022
2024-1111